Houlihan Lokey announces new head of biopharmaceutical practice

Houlihan Lokey Logo Large

Houlihan Lokey, the international investment bank, today announced that Fedora Baloiu has joined the firm as Head of the Biopharmaceutical practice in the firm’s Healthcare Group.

Ms. Baloiu will be focusing on advising pharma, biotech and biopharma services and technology clients globally. She is based in New York, reporting to Mark Francis, Managing Director and Head of the Healthcare Group. 

Ms. Baloiu joins from Goldman Sachs, where she has spent the last nine years in the Healthcare group within the Investment Banking Division in New York, focusing on pharmaceutical and biotech clients. While at Goldman, Ms. Baloiu worked on multiple M&A and financing transactions in the biopharma space and spent 18 months in the London office. Prior to Goldman Sachs, she worked in Bain & Company’s Consumer and Healthcare Group, providing strategic management consulting services to clients throughout Europe. Over the course of her career, Ms. Baloiu has advised on M&A and financing transactions with an aggregate value in excess of $65bn. 

"We are delighted that Fedora is joining our healthcare team and we look forward to collaborating with her to create significant success for clients in the biopharmaceutical sector," said Mr. Francis. "Her client relationships and depth of expertise in biopharmaceutical sector is tremendously valuable in both U.S. and Europe, where we see a sustained high level of M&A activity," he added. 

"Houlihan Lokey's Healthcare Group has had tremendous success in providing world class advice to clients and assisting them in achieving market-leading outcomes. The Healthcare team has deep relationships with strategics, financial sponsors, and financing sources and provides a broad range of services and superior advice resulting in compelling solutions for clients,” said Ms. Baloiu. "I am excited to join a market-leading Healthcare team and I look forward to working with my colleagues to continue the momentum the Group has achieved to date. I expect the Biopharma and related services to continue the tremendous growth experienced in recent years and I am eager to build upon such opportunities with a leading team," she continued.

Houlihan Lokey has approximately 1,000 employees across 20 global locations and is a long-term leader in the mid-cap M&A market. With over 30 dedicated banking professionals, Houlihan Lokey’s Healthcare Group is among the largest in financial services. Following Ms. Baloiu’s hire, the Group’s coverage capabilities span every vertical across the healthcare sector. In 2014, the Group ranked #1 for US transactions under $1bn, according to Thomson Reuters.

Ms. Baloiu holds a B.A. in Finance from Bocconi University and an MBA from Columbia Business School.

JefferiesAnd the Best Place to Work in the global financial markets 2017 is...

Register for Financial Markets News Alerts